Baxter International has temporarily halted production of certain heparin vials amid reports of serious adverse reactions to the widely used, injectable blood thinner. Baxter has not broadened a prior...
C. diff sources ‘diverse’: study
By
Tim Mullaney
Nov 01, 2013
New research challenges assumptions about how Clostridium difficile is transmitted.
Medicaid paying 32% less than Medicare Part D for medications
By
Elizabeth Newman
Jul 03, 2014
Medicaid is paying the lowest average price for 78 high-use and high-expenditure brand-name and generic drugs, a new federal report finds.
AARP: Cost of drugs for seniors rises
Mar 06, 2008
The cost of brand name drugs commonly prescribed to the elderly rose by an average of 7.4% last year, says the AARP, an increase that greatly exceeded inflation.
McKesson Alternate Site Pharmacy launches new program
Feb 23, 2016
McKesson Alternate Site Pharmacy℠ has debuted the PATH Pro™ Post-Acute Therapeutics Formulary Management Program for long-term care pharmacies.
FDA approves first generic Effexor extended release capsules for major depressive disorder
Jul 06, 2010
The Food and Drug Administration has approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder. Venlafaxine hydrochloride extended-release...
Combining two drugs may help ameliorate Alzheimer’s symptoms
By
Haymarket Media
Jan 23, 2004
Two drugs that act differently on the brain’s chemistry worked in tandem to help ameliorate Alzheimer’s disease, researchers reported in the Journal of the American Medical Association.
Pfizer mulls possible OTC switch for Lipitor
Aug 16, 2011
Pfizer is reportedly weighing an attempt at an over-the-counter switch for Lipitor – a move that could help the company recoup some of its losses when the $11 billion drug loses nationwide exclusivity...
Pharma company Teva to pay $27 million over charges of kickbacks to promote dangerous antipsychotic
By
Tim Mullaney
Mar 12, 2014
Teva Pharmaceuticals and subsidiary IVAX LLC have agreed to a $27.6 million settlement over charges that they paid kickbacks to a psychiatrist for putting nursing home residents on the antipsychotic drug...
Long-term care looks for leaders as healthcare industry adds jobs
By
McKnight's Staff
May 07, 2012
A new rise in healthcare jobs is good news for executives in senior care, an expert said Friday.